Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Albany International (AIN) Research & Development (2016 - 2025)

Historic Research & Development for Albany International (AIN) over the last 16 years, with Q3 2025 value amounting to $11.5 million.

  • Albany International's Research & Development rose 574.51% to $11.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.6 million, marking a year-over-year increase of 207.91%. This contributed to the annual value of $46.1 million for FY2024, which is 1346.4% up from last year.
  • Latest data reveals that Albany International reported Research & Development of $11.5 million as of Q3 2025, which was up 574.51% from $12.6 million recorded in Q2 2025.
  • Albany International's Research & Development's 5-year high stood at $12.7 million during Q1 2024, with a 5-year trough of $9.5 million in Q1 2021.
  • For the 5-year period, Albany International's Research & Development averaged around $10.6 million, with its median value being $10.3 million (2023).
  • Its Research & Development has fluctuated over the past 5 years, first surged by 2323.64% in 2024, then crashed by 607.19% in 2025.
  • Albany International's Research & Development (Quarter) stood at $10.0 million in 2021, then fell by 0.49% to $10.0 million in 2022, then grew by 3.69% to $10.3 million in 2023, then grew by 3.91% to $10.7 million in 2024, then rose by 6.89% to $11.5 million in 2025.
  • Its Research & Development stands at $11.5 million for Q3 2025, versus $12.6 million for Q2 2025 and $11.9 million for Q1 2025.